Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.09 0.49%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics P/S Ratio 2011-2024 | RVNC

Annual P/S Ratio Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
2.05 19 11.6 96.3 2.35 K 171 3.92 K 1.8 K 1.68 K 815 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.92 K 2.05 1.09 K